Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Blood proteins or globulins – e.g. – proteoglycans – platelet...
Reexamination Certificate
2008-01-01
2008-01-01
Lucas, Zachariah (Department: 1648)
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Blood proteins or globulins, e.g., proteoglycans, platelet...
C530S388100, C530S389400, C424S130100, C424S141100, C424S149100, C424S161100, C536S023100, C536S023500, C536S023530
Reexamination Certificate
active
07314919
ABSTRACT:
An human antibody anti-NS3 protein of the hepatitis C virus (HCV) is described, as will as synthetic and recombinant fragments thereof able to inhibit the helicase activity of the NS3 protein, both in vitro and in vivo, and uses thereof.
REFERENCES:
patent: 6534064 (2003-03-01), O'Hagan et al.
Artsaenko et al., Abrogation of hepatits C virus NS3 helicase enzymatic activity by recombinant human antibodies, Journal of General Virology, vol. 84 No. 9, pp. 2323-2332 (Sep. 2003).
Bretner, Maria, Existing and future therapeutic options for hepatitis C virus infection, Acta Biochimica polonica, vol. 52 No. 1, pp. 57-70 (2005- no date available).
Daugherty et al., Polymerase chain reaction facilitates the cloning, CDR-grafting, and rapid expression of a muring monoclonal antibody directed against . . . , Nucleic Acids Research, vol. 19 No. 9, pp. 2471-2476 (May 1991).
Esposito et al., Recombinant human antibodies specific for hepatitis C virus proteins, Archives of Virology, vol. 142 No. 3, pp. 601-610 (Mar. 1997).
Esposito et al., immunoglobulin kappa light chain, GenPept Accession CAA58108. Feb. 5, 1998.
Leroux-Roels, Geert, Development of prophylactic and therapeutic vaccines against hepatitis C virus, Expert Review of Vaccines, vol. 4 No. 3, pp. 351-371 (Jun. 2005).
Lodish et al., Molecular Cell Biology, 3d Ed., Scientific American Books Ins., NY 1995 (no date available).
Poljak et al., Structure and specificity of antibody molecules, Philosophical Transactions of the Royal Society of London, Series B: Biological Sciences, vol. 272, pp. 43-51 (Nov. 1975).
Prabhu et al., Inhibition of Hepatitis C Virus Nonstructural Protein, Helicase activity, and Viral Replication by a REcombinant Human Antibody Clone, American Journal of Pathology, vol. 165 No. 4, pp. 1163-1173 (Oct. 2004).
Rudikoff et al., Single amino acid substitution altering antigen-binding specificity, Proceedings of the National Academy of Sciences, USA, vol. 79, pp. 1979-1983 (Mar. 1982).
Stocks, Martin, Intrabodies as drug discovery tools and therapeutics, Current Opinion in Chemical Biology, vol. 9 No. 4, pp. 359-365 (Aug. 2005).
Mondelli et al., Journal of Virology, vol. 68 No. 8, pp. 4829-4836 (Aug. 1994).
Sullivan et al., Journal of Hepatology, vol. 37 No. 5, pp. 660-668 (2002).
PCT International Search Report for Biostrands S.R.L., Int'l Application No. PCT/IT02/00384, Filed Jun. 11, 2002, Dated Jul. 3, 2003. [Exhibit 1] .
N. Khalap et al.: “A recombinant human Fab inhibits helicase activity of HCV NS3 and negative strand RNA synthesis.” GASTROLOGY, vol. 120, No. 5, Apr. 2001, p. A-8 XP008014494 New York, NY USA abstract 35.
3. N. Khalap et al.: “A recombinant human Fab inhibits helicase activity of HCV NS3 and negative strand RNA synthesis.” The Faseb Journal, vol. 15, No. 4, Mar. 7, 2001 p. A-391 XP008014493 Bethesda, MD, USA abstract 322.4.
G. Esposito et al.: “A human antibody specific for hepatitis C virus core protein: synthesis in a bacterial system and characterization.” GENE, vol. 164, 1995, pp. 203-209, XP004041876 Amsterdam, The Netherlands abstract figure 5.
WO 97 12043 A (Chiron Corporation) Apr. 3, 1997 p. 3, line 11—line 12.
T. Heintges et al.: “Cloning, bacterial expression and sequencing of human antibody fragments against hepatitis C virus NS3 by phage display of a recombinatorial phagemid library.” HEPATOLOGY, vol. 28, No. 4 part 2, Oct. 1998 p. 287A XP008014496 Baltimore, MD, USA abstract 497.
Burioni Roberto
Clementi Massimo
Biostrands S.r.l.
Law Offices of Albert Wai-Kit Chan PLLC
Lucas Zachariah
LandOfFree
Human recombinant antibody against the hepatitis C (HCV) non... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Human recombinant antibody against the hepatitis C (HCV) non..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Human recombinant antibody against the hepatitis C (HCV) non... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2755773